359 related articles for article (PubMed ID: 10383161)
1. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
[TBL] [Abstract][Full Text] [Related]
2. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.
Reznikoff CA; Yeager TR; Belair CD; Savelieva E; Puthenveettil JA; Stadler WM
Cancer Res; 1996 Jul; 56(13):2886-90. PubMed ID: 8674033
[TBL] [Abstract][Full Text] [Related]
3. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.
Schwarze SR; Shi Y; Fu VX; Watson PA; Jarrard DF
Oncogene; 2001 Dec; 20(57):8184-92. PubMed ID: 11781834
[TBL] [Abstract][Full Text] [Related]
4. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
[TBL] [Abstract][Full Text] [Related]
5. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.
Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324
[TBL] [Abstract][Full Text] [Related]
6. Increased p16 levels correlate with pRb alterations in human urothelial cells.
Yeager T; Stadler W; Belair C; Puthenveettil J; Olopade O; Reznikoff C
Cancer Res; 1995 Feb; 55(3):493-7. PubMed ID: 7834615
[TBL] [Abstract][Full Text] [Related]
7. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
8. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
9. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
Xin H; Curry J; Johnstone RW; Nickoloff BJ; Choubey D
Oncogene; 2003 Jul; 22(31):4831-40. PubMed ID: 12894224
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
11. Function of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi N; Shimada K; Nakamura M; Ishida E; Ota I; Tanaka N; Fujimoto K
Clin Cancer Res; 2008 Jul; 14(14):4408-16. PubMed ID: 18628455
[TBL] [Abstract][Full Text] [Related]
12. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
[TBL] [Abstract][Full Text] [Related]
13. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
14. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation.
Brenner AJ; Stampfer MR; Aldaz CM
Oncogene; 1998 Jul; 17(2):199-205. PubMed ID: 9674704
[TBL] [Abstract][Full Text] [Related]
15. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
17. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
[TBL] [Abstract][Full Text] [Related]
19. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation.
Harada H; Nakagawa H; Oyama K; Takaoka M; Andl CD; Jacobmeier B; von Werder A; Enders GH; Opitz OG; Rustgi AK
Mol Cancer Res; 2003 Aug; 1(10):729-38. PubMed ID: 12939398
[TBL] [Abstract][Full Text] [Related]
20. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.
Costanzi-Strauss E; Strauss BE; Naviaux RK; Haas M
Exp Cell Res; 1998 Jan; 238(1):51-62. PubMed ID: 9457056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
